Clindamycin Phosphate
NDC 50090-0768
Product Information
Clindamycin Phosphate is a ANDA-approved product labeled by A-s Medication Solutions. This medication is used to treat acne. It is supplied as a product. This product entry covers the primary NDC 50090-0768 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 50090-0768?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CLINDAMYCIN PHOSPHATE (UNII: EH6D7113I8)
- CLINDAMYCIN (UNII: 3U02EL437C) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ALLANTOIN (UNII: 344S277G0Z)
- METHYLPARABEN (UNII: A2I8C7HI9T)
- POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- WATER (UNII: 059QF0KO0R)
- CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) (UNII: HHT01ZNK31)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 2676585 - clindamycin phosphate 1 % Twice-Daily Topical Gel
- RxCUI: 2676585 - Twice-Daily clindamycin 0.01 MG/MG Topical Gel
- RxCUI: 2676585 - clindamycin (as clindamycin phosphate) 1 % Twice-Daily Topical Gel
* Please review the full disclaimer at the bottom of this page.
Patient Education
Clindamycin Topical
Topical clindamycin is used to treat acne. Clindamycin is in a class of medications called lincomycin antibiotics. It works by slowing or stopping the growth of bacteria that cause acne and by decreasing swelling.
[Learn More]
* Please review the full disclaimer at the bottom of this page.